Senate Bill Not Seen As Death Knell For Skinny Label Suits
A Senate bill aiming to protect generic-drug makers from patent suits when using so-called skinny labels could give the law more clarity if passed, but it likely wouldn't halt such cases...To view the full article, register now.
Already a subscriber? Click here to view full article